This content is from: India

Ranbaxy goes to court to challenge transfer pricing ruling

Ranbaxy Laboratories, an Indian pharmaceuticals company, has said that it will challenge a transfer pricing ruling by the country's Income Tax Appellate Tribunal (ITAT) in the high court

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial